VectivBio Statistics
Share Statistics
VectivBio has n/a
shares outstanding. The number of shares has increased by null%
in one year.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| 2,707 |
| 0.25% |
Short Selling Information
The latest short interest is 168.46K, so 0.27% of the outstanding
shares have been sold short.
| 168.46K |
| 0.27% |
| 0.32% |
| 1 |
Valuation Ratios
The PE ratio is -4.08 and the forward
PE ratio is null.
VectivBio's PEG ratio is
0.12.
| -4.08 |
| n/a |
| 13.98 |
| n/a |
| 1.79 |
| -6.79 |
| 0.12 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for VectivBio.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 9.14,
with a Debt / Equity ratio of 0.05.
| 9.14 |
| 9.14 |
| 0.05 |
| -0.13 |
| -0.19 |
| -25.45 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| undefined |
| 0.11 |
| n/a |
Taxes
| 107K |
| -0.11% |
Stock Price Statistics
The stock price has increased by 0.12% in the
last 52 weeks. The beta is 0.1, so VectivBio's
price volatility has been higher than the market average.
| 0.1 |
| 0.12% |
| 14.67 |
| 9.72 |
| 67.1 |
| 1,100,434 |
Income Statement
In the last 12 months, VectivBio had revenue of 27.34M
and earned -93.73M
in profits. Earnings per share was -2.12.
| 27.34M |
| 27.34M |
| -80.52M |
| -93.73M |
| -79.85M |
| -90.46M |
| -2.12 |
Full Income Statement Balance Sheet
The company has 221.42M in cash and 10.46M in
debt, giving a net cash position of 210.95M.
| 221.42M |
| 10.46M |
| 210.95M |
| -207.76M |
| n/a |
| n/a |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -56.26M
and capital expenditures -74K, giving a free cash flow of -56.33M.
| -56.26M |
| -74K |
| -56.33M |
| -1.28 |
Full Cash Flow Statement Margins
Gross margin is 100%, with operating and profit margins of -294.52% and -342.84%.
| 100% |
| -294.52% |
| -342.45% |
| -342.84% |
| -292.04% |
| -294.52% |
| -206.04% |